Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry

Poison centers reported a sharp increase in calls related to accidental overdoses of the diabetes and weight-loss drug semaglutide (Ozempic, Wegovy). (CNN)

Some patients with diabetes are having a tougher time getting reimbursed for their GLP-1 agonists, a byproduct of insurers tightening the screws on prescribing the class of drugs for weight loss. (Reuters)

A novel, oral GLP-1 receptor agonist significantly reduced HbA1c and weight (-1.02% and -3.26% placebo-adjusted change with 90 mg, respectively) after 12 weeks in people with type 2 diabetes in a phase IIa trial, announced developer Structure Therapeutics.

Science has crowned GLP-1 agonists as its 2023 Breakthrough of the Year.

Beware of illegally marketed over-the-counter supplements that claim to treat or even cure diabetes, the FDA warned.

Emergency department visits by adults with diabetes jumped more than 50% from 2012 to 2021, CDC data indicated, increasing from 48.6 to 74.9 visits per 1,000 adults.

Ohio lawmakers passed a bill that blocks physicians from providing gender-affirming care to transgender youth; Gov. Mike DeWine (R) has not yet indicated whether he will sign it. (WKSU)

Tandem Diabetes Care launched its revamped diabetes management platform for insulin pump users. (MedTech Dive)

The prevalence of preschool-age children with severe obesity in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) increased from 2016 to 2020, according to a study in Pediatrics.

In an opinion piece, Sen. Bernie Sanders (I-Vt.) blamed the food and beverage industries for the diabetes epidemic. (USA Today)

This is why Oprah and WeightWatchers are embracing weight-loss drugs. (NPR)

Please enable JavaScript to view the

comments powered by Disqus.